Norman Samuel Radin
Affiliations: | 1952-1960 | Northwestern University, Evanston, IL | |
| 1960-1991 | Mental Health Research Institute | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
NeurochemistryWebsite:
http://normradin.com/Google:
"Norman Samuel Radin"Bio:
(1920 - 2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679375/
http://um2017.org/faculty-history/faculty/norman-s-radin
http://www.jbc.org/content/184/2/745.full.pdf
http://www.jbc.org/content/184/2/755.full.pdf
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David Rittenberg | grad student | 1949 | Columbia | |
| (The biosynthesis of heme.) | ||||
| David Shemin | grad student | 1949 | Columbia | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Radin NS. (2004) Sphingolipids as coenzymes in anion transfer and tumor death. Bioorganic & Medicinal Chemistry. 12: 6029-37 |
| Radin NS. (2002) Cancer progression in the kidney and prostate: vital roles of sphingolipids in chemotherapy. Urology. 60: 562-8 |
| Chatterjee S, Cleveland T, Shi WY, et al. (1997) Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase. Glycoconjugate Journal. 13: 481-6 |
| RADIN NS. (1996) THE HYDROXY FATTY ACIDS: ISOLATION, STRUCTURE DETERMINATION, QUANTITATION. Journal of the American Oil Chemists' Society. 42: 569-80 |
| Radin NS. (1996) Treatment of Gaucher disease with an enzyme inhibitor. Glycoconjugate Journal. 13: 153-7 |
| Abe A, Shayman JA, Radin NS. (1996) A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides. The Journal of Biological Chemistry. 271: 14383-9 |
| Abe A, Radin NS, Shayman JA. (1996) Induction of glucosylceramide synthase by synthase inhibitors and ceramide. Biochimica Et Biophysica Acta. 1299: 333-41 |
| Radin NS. (1994) Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase. Molecular and Chemical Neuropathology. 21: 111-27 |
| Abe A, Wu D, Shayman JA, et al. (1993) Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C. European Journal of Biochemistry. 210: 765-73 |
| Radin NS, Shayman JA. (1993) Use of an Inhibitor of Glucosylceramide Synthesis, D-1-Phenyl-2-decanoylamino-3-morpholino-1 -propanol Neuroprotocols. 3: 145-155 |